$FLUT

Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls

Citi upgraded Flutter (FLUT) to Buy with a $91 target. Cantor upgraded Humana (HUM) to Overweight with a $460 target. TD Cowen upgraded Marvell (MRVL) to Buy with a $350 target. Evercore upgraded NetApp (NTAP) to Outperform with a $300 target. Citi upgraded XPO (XPO) to Buy with a $224 target. UBS downgraded AppFolio (APPF) to Neutral with a $220 target. William Blair downgraded Option Care Health (OPCH) after its acquisition by CD&R and McKesson (MCK).

Original reporting
Published Oct 7, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 2:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls — source image
Decision brief

The 30-second read

$FLUTBullishLow
01

Why it matters

While each upgrade or downgrade offers a directional cue, the collective nature suggests modest market influence rather than a single catalyst.

02

Market read

Analyst rating changes provide short‑term trading ideas but are not major catalysts; overall relevance is moderate.

03

What to watch

Potential macro headwinds and earnings volatility could temper the impact of these upgrades.

Relevance 5/10Novelty 4/10Timing: today

Background

The article compiles recent analyst rating changes across a range of U.S.-listed companies, providing new target price adjustments and coverage initiations.

Company-level read

Ticker impact

$FLUTBullishMedium confidence
Context

Citi upgraded Flutter Entertainment to Buy with a $91 price target.

Expected impact

likely upward as investors price the new buy rating

Evidence & confidence

Analyst upgrade with a lower target suggests improved outlook.

$HUMBullishMedium confidence
Context

Cantor Fitzgerald upgraded Humana to Overweight with a $460 price target.

Expected impact

likely upward due to higher target and confidence in Medicare margin

Evidence & confidence

Higher target and sector confidence may attract buying.

$MRVLBullishMedium confidence
Context

TD Cowen upgraded Marvell to Buy with a $350 price target.

Expected impact

likely upward as investors respond to strong connectivity franchise thesis

Evidence & confidence

Target increase signals stronger growth expectations.

$NTAPBullishMedium confidence
Context

Evercore ISI upgraded NetApp to Outperform with a $300 price target.

Expected impact

likely upward given higher target and growth guidance

Evidence & confidence

Analyst sees growth potential despite conservative guidance.

$XPOBullishMedium confidence
Context

Citi upgraded XPO to Buy with a $224 price target.

Expected impact

likely upward as free cash flow outlook improves

Evidence & confidence

Higher target reflects expected cash flow growth.

$APPFBearishMedium confidence
Context

UBS downgraded AppFolio to Neutral from Buy with a $220 price target.

Expected impact

likely downward as valuation concerns are highlighted

Evidence & confidence

Shift to neutral suggests reduced upside.

$OPCHBearishMedium confidence
Context

William Blair downgraded Option Care Health to Market Perform after acquisition announcement.

Expected impact

likely downward or flat despite acquisition news

Evidence & confidence

Rating cut reflects perceived integration risk.

$MHKBearishMedium confidence
Context

RBC Capital downgraded Mohawk Industries to Underperform with a $112 price target.

Expected impact

likely downward as lower target signals weaker outlook

Evidence & confidence

Target cut reflects concerns over future earnings.

Market effects

Broad coverage upgrades may lift related tech and healthcare sectors.

U.S. equities may see modest positive bias from multiple upgrades.

Limited; primarily U.S. market impact.

Counterpoint

Investors may view the numerous upgrades as overoptimistic, preferring a wait-and-see stance.

Key entities

  • Citi

    Upgraded FLUT and XPO

  • Cantor Fitzgerald

    Upgraded HUM

  • TD Cowen

    Upgraded MRVL

  • Evercore ISI

    Upgraded NTAP

  • UBS

    Downgraded APPF

Related articles

$BROHighAI 8/10

Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.